In these separate phase 3 trials, gastrointestinal side effects were reported more frequently with the highest dose of retatrutide than with tirzepatide
They contain the same active drug (oral semaglutide), but they are not the same
Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage
Retatrutide Overview Retatrutide is a first-in-class investigational compound developed by Eli Lilly, currently being studied for its potential role in managing complex metabolic conditions, including obesity, type 2 diabetes, and fatty liver disease
Taming the Appetite Beast : They mess with the brain signals that make us hungry, dialling them down
30, 2024, the FDA has received more than 200 reports of adverse events from compounded tirzepatide and almost 400 similar reports from compounded semaglutide